Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

80.95
Delayed Data
As of Jan 23
 -0.46 / -0.57%
Today’s Change
63.76
Today|||52-Week Range
86.27
+13.00%
Year-to-Date
Crossvault Capital Management LLC Buys Southwest Airlines Co, Salesforce. ...
Jan 23 / GuruFocus News - Paid Partner Content
Gilead Collaborates with Pfizer for Yescarta Combo Study
Jan 19 / Zacks.com - Paid Partner Content
Celgene (CELG) to Acquire Juno Therapeutics for $9 Billion
Jan 23 / Zacks.com - Paid Partner Content
Rhenman & Partners Asset Management AB Buys ACADIA Pharmaceuticals Inc, Gilead Scienc...
Jan 19 / GuruFocus News - Paid Partner Content
Bluebird Up on Buyout Speculation After Celgene/Juno Deal
Jan 23 / Zacks.com - Paid Partner Content
CVS and Gilead Sciences Hit the Casualty List
Jan 19 / GuruFocus News - Paid Partner Content
LaFleur & Godfrey LLC Buys Gilead Sciences Inc, US Bancorp, Goldman Sachs Group Inc, ...
Jan 22 / GuruFocus News - Paid Partner Content
Professional Advisory Services Inc Buys Analog Devices Inc, Intel Corp, Gilead Scienc...
Jan 19 / GuruFocus News - Paid Partner Content
Healthcare ETFs to Watch As Q4 Earnings Unfold
Jan 22 / Zacks.com - Paid Partner Content
Celgene Could Be Bulking Up Very Fast
Jan 19 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close81.41
Today’s open81.23
Day’s range80.91 - 82.18
Volume7,198,762
Average volume (3 months)8,182,105
Market cap$106.3B
Data as of 4:15pm ET, 01/23/2018

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-24.76%
Earnings growth (next 5 years)-6.80%
Revenue growth (last year)-5.37%
P/E ratio9.2
Price/Sales3.21
Price/Book5.65

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-0.34-0.18%
BIIBBiogen-0.89-0.26%
ILMNIllumina Inc-2.25-0.92%
----
Data as of 4:00pm ET, 01/23/2018

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)$1.67
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts